Cargando…
Neurological Manifestations in a Cohort of Egyptian Patients with COVID-19: A Prospective, Multicenter, Observational Study
Background: The COVID-19 pandemic has reached over 276 million people globally with 5.3 million deaths as of 22nd December 2021. COVID-19-associated acute and long-term neurological manifestations are well recognized. The exact profile and the timing of neurological events in relation to the onset o...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773531/ https://www.ncbi.nlm.nih.gov/pubmed/35053817 http://dx.doi.org/10.3390/brainsci12010074 |
_version_ | 1784636113961353216 |
---|---|
author | Mekkawy, Doaa A. Hamdy, Sherif Abdel-Naseer, Maged Shehata, Hatem S. Halfawy, Ahmed Al Shalaby, Nevin M. Shehata, Ghaydaa A. Ali, Anwar M. Elmazny, Alaa Ahmed, Sandra M. Ismail, Jumana H. Ibraheim, Aml Abdel-Hamid, Hoda M. Magdy, Rehab Kabara Ayoub, Younan Taha, Ahmed E. Merghany, Nahla Soliman, Nourhan M. Elshebawy, Haidy Abdelal, Samar E. S. El-Ghoneimy, Lobna Al-Athwari, Aussan Kishk, Nirmeen A. Nada, Mona A. F. Farghaly, Marwa Hassan, Amr Hegazy, Mohamed I. Abdelalim, Ahmed Mourad, Husam S. Hassouna, Amira Othman, Alshimaa S. Wijeratne, Tissa |
author_facet | Mekkawy, Doaa A. Hamdy, Sherif Abdel-Naseer, Maged Shehata, Hatem S. Halfawy, Ahmed Al Shalaby, Nevin M. Shehata, Ghaydaa A. Ali, Anwar M. Elmazny, Alaa Ahmed, Sandra M. Ismail, Jumana H. Ibraheim, Aml Abdel-Hamid, Hoda M. Magdy, Rehab Kabara Ayoub, Younan Taha, Ahmed E. Merghany, Nahla Soliman, Nourhan M. Elshebawy, Haidy Abdelal, Samar E. S. El-Ghoneimy, Lobna Al-Athwari, Aussan Kishk, Nirmeen A. Nada, Mona A. F. Farghaly, Marwa Hassan, Amr Hegazy, Mohamed I. Abdelalim, Ahmed Mourad, Husam S. Hassouna, Amira Othman, Alshimaa S. Wijeratne, Tissa |
author_sort | Mekkawy, Doaa A. |
collection | PubMed |
description | Background: The COVID-19 pandemic has reached over 276 million people globally with 5.3 million deaths as of 22nd December 2021. COVID-19-associated acute and long-term neurological manifestations are well recognized. The exact profile and the timing of neurological events in relation to the onset of infection are worth exploring. The aim of the current body of work was to determine the frequency, pattern, and temporal profile of neurological manifestations in a cohort of Egyptian patients with confirmed COVID-19 infection. Methods: This was a prospective study conducted on 582 hospitalized COVID-19 patients within the first two weeks of the diagnosis of COVID-19 to detect any specific or non-specific neurological events. Results: The patients’ mean (SD) age was 46.74 (17.26) years, and 340 (58.42%) patients were females. The most commonly encountered COVID-19 symptoms were fever (90.72%), cough (82.99%), and fatigue (76.98%). Neurological events (NE) detected in 283 patients (48.63%) and were significantly associated with a severe COVID-19 at the onset (OR: 3.13; 95% CI: 2.18–4.51; p < 0.0001) and with a higher mortality (OR: 2.56; 95% CI: 1.48–5.46; p = 0.019). The most frequently reported NEs were headaches (n = 167) and myalgias (n = 126). Neurological syndromes included stroke (n = 14), encephalitis (n = 12), encephalopathy (n = 11), transverse myelitis (n = 6) and Guillain-Barré syndrome (n = 4). Conclusions: Neurological involvement is common (48.63%) in COVID-19 patients within the first two weeks of the illness. This includes neurological symptoms such as anosmia, headaches, as well as a constellation of neurological syndromes such as stroke, encephalitis, transverse myelitis, and Guillain-Barré syndrome. Severity of acute COVID-19 illness and older age are the main risk factors. |
format | Online Article Text |
id | pubmed-8773531 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87735312022-01-21 Neurological Manifestations in a Cohort of Egyptian Patients with COVID-19: A Prospective, Multicenter, Observational Study Mekkawy, Doaa A. Hamdy, Sherif Abdel-Naseer, Maged Shehata, Hatem S. Halfawy, Ahmed Al Shalaby, Nevin M. Shehata, Ghaydaa A. Ali, Anwar M. Elmazny, Alaa Ahmed, Sandra M. Ismail, Jumana H. Ibraheim, Aml Abdel-Hamid, Hoda M. Magdy, Rehab Kabara Ayoub, Younan Taha, Ahmed E. Merghany, Nahla Soliman, Nourhan M. Elshebawy, Haidy Abdelal, Samar E. S. El-Ghoneimy, Lobna Al-Athwari, Aussan Kishk, Nirmeen A. Nada, Mona A. F. Farghaly, Marwa Hassan, Amr Hegazy, Mohamed I. Abdelalim, Ahmed Mourad, Husam S. Hassouna, Amira Othman, Alshimaa S. Wijeratne, Tissa Brain Sci Article Background: The COVID-19 pandemic has reached over 276 million people globally with 5.3 million deaths as of 22nd December 2021. COVID-19-associated acute and long-term neurological manifestations are well recognized. The exact profile and the timing of neurological events in relation to the onset of infection are worth exploring. The aim of the current body of work was to determine the frequency, pattern, and temporal profile of neurological manifestations in a cohort of Egyptian patients with confirmed COVID-19 infection. Methods: This was a prospective study conducted on 582 hospitalized COVID-19 patients within the first two weeks of the diagnosis of COVID-19 to detect any specific or non-specific neurological events. Results: The patients’ mean (SD) age was 46.74 (17.26) years, and 340 (58.42%) patients were females. The most commonly encountered COVID-19 symptoms were fever (90.72%), cough (82.99%), and fatigue (76.98%). Neurological events (NE) detected in 283 patients (48.63%) and were significantly associated with a severe COVID-19 at the onset (OR: 3.13; 95% CI: 2.18–4.51; p < 0.0001) and with a higher mortality (OR: 2.56; 95% CI: 1.48–5.46; p = 0.019). The most frequently reported NEs were headaches (n = 167) and myalgias (n = 126). Neurological syndromes included stroke (n = 14), encephalitis (n = 12), encephalopathy (n = 11), transverse myelitis (n = 6) and Guillain-Barré syndrome (n = 4). Conclusions: Neurological involvement is common (48.63%) in COVID-19 patients within the first two weeks of the illness. This includes neurological symptoms such as anosmia, headaches, as well as a constellation of neurological syndromes such as stroke, encephalitis, transverse myelitis, and Guillain-Barré syndrome. Severity of acute COVID-19 illness and older age are the main risk factors. MDPI 2022-01-01 /pmc/articles/PMC8773531/ /pubmed/35053817 http://dx.doi.org/10.3390/brainsci12010074 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mekkawy, Doaa A. Hamdy, Sherif Abdel-Naseer, Maged Shehata, Hatem S. Halfawy, Ahmed Al Shalaby, Nevin M. Shehata, Ghaydaa A. Ali, Anwar M. Elmazny, Alaa Ahmed, Sandra M. Ismail, Jumana H. Ibraheim, Aml Abdel-Hamid, Hoda M. Magdy, Rehab Kabara Ayoub, Younan Taha, Ahmed E. Merghany, Nahla Soliman, Nourhan M. Elshebawy, Haidy Abdelal, Samar E. S. El-Ghoneimy, Lobna Al-Athwari, Aussan Kishk, Nirmeen A. Nada, Mona A. F. Farghaly, Marwa Hassan, Amr Hegazy, Mohamed I. Abdelalim, Ahmed Mourad, Husam S. Hassouna, Amira Othman, Alshimaa S. Wijeratne, Tissa Neurological Manifestations in a Cohort of Egyptian Patients with COVID-19: A Prospective, Multicenter, Observational Study |
title | Neurological Manifestations in a Cohort of Egyptian Patients with COVID-19: A Prospective, Multicenter, Observational Study |
title_full | Neurological Manifestations in a Cohort of Egyptian Patients with COVID-19: A Prospective, Multicenter, Observational Study |
title_fullStr | Neurological Manifestations in a Cohort of Egyptian Patients with COVID-19: A Prospective, Multicenter, Observational Study |
title_full_unstemmed | Neurological Manifestations in a Cohort of Egyptian Patients with COVID-19: A Prospective, Multicenter, Observational Study |
title_short | Neurological Manifestations in a Cohort of Egyptian Patients with COVID-19: A Prospective, Multicenter, Observational Study |
title_sort | neurological manifestations in a cohort of egyptian patients with covid-19: a prospective, multicenter, observational study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773531/ https://www.ncbi.nlm.nih.gov/pubmed/35053817 http://dx.doi.org/10.3390/brainsci12010074 |
work_keys_str_mv | AT mekkawydoaaa neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT hamdysherif neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT abdelnaseermaged neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT shehatahatems neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT halfawyahmedal neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT shalabynevinm neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT shehataghaydaaa neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT alianwarm neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT elmaznyalaa neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT ahmedsandram neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT ismailjumanah neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT ibraheimaml neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT abdelhamidhodam neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT magdyrehab neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT kabaraayoubyounan neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT tahaahmede neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT merghanynahla neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT solimannourhanm neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT elshebawyhaidy neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT abdelalsamares neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT elghoneimylobna neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT alathwariaussan neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT kishknirmeena neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT nadamonaaf neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT farghalymarwa neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT hassanamr neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT hegazymohamedi neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT abdelalimahmed neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT mouradhusams neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT hassounaamira neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT othmanalshimaas neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy AT wijeratnetissa neurologicalmanifestationsinacohortofegyptianpatientswithcovid19aprospectivemulticenterobservationalstudy |